Free Cash Flow

With two blockbuster cancer drugs driving record revenue, all eyes are on Syndax's upcoming earnings call for its 2026 outlook and growth strategy.

The safety science giant posted record 2025 earnings and a strong 2026 outlook, sharpening its focus on high-growth tech with a key divestiture.

BrainsWay's strategic investment in BrainStim aims to expand Deep TMS access in Canada, targeting veterans and first responders with advanced mental health care.

Riding a wave of strong financial performance, the aerospace materials giant is boosting its buyback authorization to $620 million, underscoring its bullish outlook.

As Signet prepares its Q4 earnings, all eyes are on whether its brand power can overcome cautious consumer spending and set the tone for the luxury market.

Specialist asset manager Sprott Inc. leverages a volatile market and geopolitical tensions, riding a precious metals boom to record profits and AUM growth.

Amid regional conflict, InterCure reports NIS 265M revenue, enters German market, and makes strategic US moves, showcasing remarkable resilience and growth.

Cenovus Energy reports a record-breaking quarter, with upstream production soaring past 900,000 BOE/d after its landmark acquisition of MEG Energy.

Early data reveals a novel immunotherapy, STC-1010, may activate the immune system against a common, treatment-resistant form of colorectal cancer.

Despite a massive accounting-driven net loss, Renault Group's 2025 results reveal robust operational health, sales growth, and a successful EV push.

As VerticalScope preps its 2025 results, investors watch if its pivot to AI and e-commerce can overcome ad market and search engine challenges.

The Canadian miner announces its first-ever dividend and a share buyback, balancing ambitious growth with a new focus on returning capital to investors.

Riding a wave of record free cash flow and a bullish gold market, Kinross has announced a significant dividend increase, signaling confidence to investors.

Backed by strong earnings, Jackson Financial boosts its shareholder payout, signaling confidence and a robust capital return strategy in the annuity market.

The AI analytics firm posted strong 2025 results, unveiled new AI agents, and boosted its buyback program, signaling confidence in its enterprise strategy.

After a major pipeline pivot, Keros Therapeutics faces investors with a new lead drug, a fortified balance sheet, and a high-stakes strategy to prove.

TPL shatters 2025 financial records despite price headwinds, fueled by strategic acquisitions and a major $50 million investment in data infrastructure.

Wyndham Hotels & Resorts reports record development but takes a major Q4 loss from a franchisee's insolvency, yet signals confidence with a dividend hike.

Aurora executives face Wall Street at key March conferences to justify high cash burn with a clear path to commercializing their driverless truck tech.

Compass Diversified sets its earnings date, putting its post-Lugano strategy and portfolio health under intense scrutiny from investors.